BANK VONTOBEL/PUT/NOVARTIS N/80/0.1/20.12.24 Share Price

Warrant

DE000VM3V7X4

Delayed Deutsche Boerse AG 11:34:26 28/06/2024 pm IST
0.068 EUR -5.56% Intraday chart for BANK VONTOBEL/PUT/NOVARTIS N/80/0.1/20.12.24
Current month-29.90%
1 month-43.33%
Date Price Change
28/24/28 0.068 -5.56%
27/24/27 0.072 +5.88%
26/24/26 0.068 -1.45%
25/24/25 0.069 -.--%
24/24/24 0.069 -14.81%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 11:34 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying NOVARTIS AG
IssuerLogo Issuer Vontobel Vontobel
WKN VM3V7X
ISINDE000VM3V7X4
Date issued 11/10/2023
Strike 80 CHF
Maturity 20/12/2024 (173 Days)
Parity 10 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.59
Lowest since issue 0.063
Spread 0.01
Spread %13.51%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107 USD
Average target price
110.3 USD
Spread / Average Target
+3.04%
Consensus